Silvana Chiara

4.7k citations
36 papers · 3.0k indexed · 3 hit papers · h-index 16

Silvana Chiara

35 papers receiving 2.9k citations

Hit Papers

FOLFOXIRI plus bevacizumab versus FOLFIRI plus bev...7332007202620132019250500750

Peers

Silvana Chiara
Comparison fields: 5 of 88
  • Hepatology 914
  • Oncology 2.5k
  • Pathology and Forensic Medicine 570
  • Pulmonary and Respiratory Medicine 922
  • Cancer Research 369
Replace J-Y Douillard with:
J-Y Douillard France
Emmanuel Achille France
Seong Hyeon Yun South Korea
J. T. Hartmann Germany
Benoist Chibaudel France
Giacomo Cartenì Italy
Maurizio Cosimelli Italy
Elizabeth Poplin United States
Salvatore Artale Italy
G.J. Creemers Netherlands
Silvana Chiara relative to J-Y Douillard France J-Y Douillard's profile →
Citations per field
00.5×3.2×
J-Y Douillard · 1×
Citations per year

Countries citing papers authored by Silvana Chiara

Since Specialization
Citations

This map shows the geographic impact of Silvana Chiara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvana Chiara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvana Chiara more than expected).

Fields of papers citing papers by Silvana Chiara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvana Chiara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvana Chiara. The network helps show where Silvana Chiara may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Silvana Chiara, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Silvana Chiara Line = papers co-authored together Silvana Chiara links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20185
2 201733
3 201631
4
FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE studybreakdown →
2015733
5
Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancerbreakdown →
2014720
6 20132
7 20130
8 201226
9 200863
10
Phase III Trial of Infusional Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan (FOLFOXIRI) Compared With Infusional Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) As First-Line Treatment for Metastatic Colorectal Cancer: The Gruppo Oncologico Nord Ovestbreakdown →
2007872
11 200614
12 200312
13 200115
14 200116
15 199875
16 199444
17 199441
18 199348
19 199329
20 19923

About Silvana Chiara

Silvana Chiara is a scholar working on Oncology, Reproductive Medicine and Pulmonary and Respiratory Medicine, having authored 36 papers that have together received 3.0k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (18 papers), Cancer Treatment and Pharmacology (12 papers), Ovarian cancer diagnosis and treatment (7 papers), Colorectal and Anal Carcinomas (6 papers), Gastric Cancer Management and Outcomes (6 papers), Intraperitoneal and Appendiceal Malignancies (5 papers), Cancer Genomics and Diagnostics (5 papers) and Lung Cancer Treatments and Mutations (4 papers). The work is most often cited by research in Hepatology (914 citations), Oncology (2.5k citations) and Pathology and Forensic Medicine (570 citations). Silvana Chiara has collaborated with scholars based in Italy, United Kingdom and United States. Frequent co-authors include Alfredo Falcone, Giacomo Allegrini, Gianluca Masi, Cristina Granetto, Fotios Loupakis, Chiara Cremolini, Luca Boni, Enrico Cortesi, Alberto Zaniboni and Giuseppe Tonini. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Gynecologic Oncology, British Journal of Cancer and International Journal of Radiation Oncology*Biology*Physics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026